Ghrelin in Diabetes and Metabolic Syndrome
Joint Authors
Uusitupa, Matti
Kolehmainen, Marjukka
Ukkola, Olavi
Pulkkinen, Leena
Source
International Journal of Peptides
Issue
Vol. 2010, Issue 2010 (31 Dec. 2010), pp.1-11, 11 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2010-04-27
Country of Publication
Egypt
No. of Pages
11
Main Subjects
Abstract EN
Metabolic syndrome is a cluster of related risk factors for cardiovascular disease, type 2 diabetes and liver disease.
Obesity, which has become a global public health problem, is one of the major risk factors for development of metabolic syndrome and type 2 diabetes.
Obesity is a complex disease, caused by the interplay between environmental and genetic factors.
Ghrelin is one of the circulating peptides, which stimulates appetite and regulates energy balance, and thus is one of the candidate genes for obesity and T2DM.
During the last years both basic research and genetic association studies have revealed association between the ghrelin gene and obesity, metabolic syndrome or type 2 diabetes
American Psychological Association (APA)
Pulkkinen, Leena& Ukkola, Olavi& Kolehmainen, Marjukka& Uusitupa, Matti. 2010. Ghrelin in Diabetes and Metabolic Syndrome. International Journal of Peptides،Vol. 2010, no. 2010, pp.1-11.
https://search.emarefa.net/detail/BIM-457245
Modern Language Association (MLA)
Pulkkinen, Leena…[et al.]. Ghrelin in Diabetes and Metabolic Syndrome. International Journal of Peptides No. 2010 (2010), pp.1-11.
https://search.emarefa.net/detail/BIM-457245
American Medical Association (AMA)
Pulkkinen, Leena& Ukkola, Olavi& Kolehmainen, Marjukka& Uusitupa, Matti. Ghrelin in Diabetes and Metabolic Syndrome. International Journal of Peptides. 2010. Vol. 2010, no. 2010, pp.1-11.
https://search.emarefa.net/detail/BIM-457245
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-457245
